Pictet Asset Management (Switzerland)’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$531K Buy
20,969
+114
+0.5% +$2.87K ﹤0.01% 1216
2023
Q1
$540K Buy
20,855
+1,858
+10% +$49.7K ﹤0.01% 1209
2022
Q4
$449K Sell
18,997
-41,449
-69% -$1.12M ﹤0.01% 1305
2022
Q3
$1.53M Buy
60,446
+1,850
+3% +$64.9K ﹤0.01% 961
2022
Q2
$1.95M Sell
58,596
-899,470
-94% -$38.2M ﹤0.01% 945
2022
Q1
$69.1M Buy
958,066
+85,799
+10% +$6.18M 0.08% 267
2021
Q4
$80.1M Buy
872,267
+101,852
+13% +$12.2M 0.08% 259
2021
Q3
$97.7M Buy
+770,415
New +$112M 0.11% 229

Other funds holding TDOC

Pictet Asset Management (Switzerland)'s TDOC Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Teladoc Health (TDOC) stake by 0.55% in Q2 2023, buying an estimated $2.87K and bringing the position to 20,969 shares worth $531K. The position accounts for ﹤0.01% of the portfolio, ranked #1216.

Pictet Asset Management (Switzerland) first reported a position in TDOC in Q3 2021 and has held it in 8 quarters since. The position peaked at $97.7M in Q3 2021. 432 funds tracked by Wall St. Rank hold TDOC as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 20,969 shares of Teladoc Health worth $531K as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 114 Teladoc Health shares in Q2 2023, an estimated $2.87K.
  • Teladoc Health made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1216 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Teladoc Health in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Teladoc Health position peaked at $97.7M in Q3 2021.
  • 432 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.